|
Martin E. Evans, M.D.
Professor of Medicine, Division of Infectious
Diseases
Fellowship Director, Division of Infectious Diseases
Chair, Task Force for Bioterrorism Preparedness
Medical School
The University of Virginia School of Medicine
Residency
Wilford Hall United States Air Force Medical Center, San Antonio
Fellowships
Infectious Diseases, Vanderbilt University School of Medicine
Infectious Diseases and Pathology, Vanderbilt University School of Medicine
Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine, Subspecialty of Infectious Diseases
American Board of Pathology, Special Competence in Medical Microbiology
Clinical Interests
Hospital infection control
Antibiotic Resistance
Research Interest
Pharmacokinetics, pharmocodynamics, and fluoroquinolone resistance in
Staphylococcus aureus
Current Grant Activity
| Project Title: |
Optimizing Dosing to Prevent Antibiotic
Resistance |
| Sponsor: |
National Institutes of Health (RO-1 GM066072) |
| Role: |
Principal Investigator |
| Begin/end: |
9/01/02–8/31/06 |
| |
|
| Project Title: |
Bioterrorism Training for Hospital
and Community-based Pharmacists |
| Sponsor: |
HRSA |
| Role: |
Co-Investigator |
| Begin/end: |
10/1/03-9/30/05 |
2003/2004 Publications
Baker, B., Evans, M.E., deCastro, F., and
Schosser, R. leprosy in a Mexican immigrant. J KY Med
Assoc 2003;101:419-424.
Rapp, R.P., Evans, M.E., Martin, C., Ofotokun,
I., Empey, K.L., and Armistead, J.A. Drug Costs and bacterial
susceptibility after implementing a single-fluoroquinolone use policy at
a university hospital. Curr Med Res Opinion
2004;20:469-476.
Greenberg, R.N., Schosser, R.H., Plummer, E.A.,
Roberts, S.E., Caldwell, M.A., Hargis, D.L., Rudy, D.W., Evans,
M.E. and Hopkins, R.J. Urticaria, exanthems, and other benign
dermatologic reactions to smallpox vaccintaion in adults. Clin
Infect Dis 2004; 38:958:965.
Campion, J.J, McNamara, P.J., and Evans, M.E.
Evolution of ciprofloxacin-resistant Staphylococcus aureus in vivo
pharmacokinetic environments. Antimicrob Agents Chemother
2004;48:4733-4744.
Evans, M.E. Gene Therapy and Infection
Control (Chapter 19). In Wenzel, R.P. (Ed.) Prevention
and Control of Nosocomial Infections, 4th Edition, Lippincott
Williams & Wilkins, Baltimroe, MD, 2003:262-278.
Weber, D.J., Evans, M.E., Rutala, W.A.
Infection Control in Gene Therpay (Chapter 72). In Mayhall, C.G.
(Ed.) Hospital Epidemiology and Infection Control, 3rd Edition,
Lippincott Williams, & Wilkins, Baltimore, MD, 2004:1279-1288.
2002/2003 Publications
Empey, K.M., Rapp, R.P., Evans, M.E. The effect of an
antimicrobial formulary change on resistance patterns. Pharmacother
2002;22:81-87.
Rapp, R.P., Ribes, J., Overman, S., Darkow, T., Evans, M.E. A decade of antimicrobial susceptibilities at the University
of Kentucky hospital. Ann Pharmacother 2002;36:596-604.
Evans, M.E. and Lesnaw, J.A. Infection
control for gene therapy: a busy physician’s primer. Clin Infect
Dis 2002;35:597-605.
Evans, M.E. Selection of oxacillin-resistance
in oxacillin-sensitive Staphylococcus aureus by exposure to ciprofloxacin
but not piperacillin/tazobactam. Eur J Clin Microbiol Infect Dis
2002;21:621-623.
Ridings, H., Evans,
M.E. Understanding the threat of smallpox. J Am Acad Physician
Assist 2002;15:41-46.
Rapp, R.P., and Evans,
M.E. The effect of hospital antimicrobial use alteration on resistance
in gram-negative bacteria: a review. Ochsner
Clinic Reports on Serious Hospital Infections 2002;14;1-8.
Baker, B., Evans, M., deCastro, F.,
and Schosser, R. Leprosy in a Mexican immigrant. J
Ky Med Assoc 2003;101:419-424.
Evans, M.E. Gene Therapy and Infection Control
(Chapter 19). In Wenzel, R. P. (Ed.) Prevention and Control of Nosocomial
Infections, 4th Edition, Lippincott Williams & Wilkins, Baltimore,
MD, 2003:262-278.
2003/2004 Abstracts
Martin, C.A., Berry, S.E., and Evans, M.E.
Improvement in the timing of perioperative antimicrobial prophylaxis
when administered upon induction of anesthesia. Interscience
Conference on Antimicrobial Agents and Chemotherpay (ICAAC),
September14-17, 2003, Chicago.
Campion, J.J, McNamara, P.J., and Evans, M.E.
Selection of fluoroquinolone-resistant methicillin resistant
Staphylococcus aureus: comparison of garenoxacin, gatifloxacin,
and ciprofloaxacin. Interscience Conference on Antimicirobial
Agents and Chemotherapy (ICAAC), September 14-17, 2003, Chicago.
Voils, S. A., Lane, M.T., Evans, M.E., Rapp,
R.P. Non-infectious uses of antibiotics: Efficacious or
selecting resistance. AM Soc Health Systems Pharmacists mid-year
meeting, New Orleans, December, 2003.
Campion, J.J., Evans, M.E.
Pharmacodynamic modeling of the selection of gr1A mutants of methicillin-resistant
Staphylococcus aureus by garenoxacin, gatifloxacin, and ciprofloxacin.
11th International Symposium on Staphylococci & Staphylococcal
Infections, Charleston, N.C., October 24-27,. 2004.
Campion, J.J, Evans, M.E.
Pharmacodynamic modeling of levofloxacin resistance in Staphylococcus
aureus populations exposed to simulated in vitro pharmacokinetic
profiles: comparison with ciprofloxacin. 11th International
symposium on Staphylococci & Staphylococcal Infections, Charleston,
N.C., October 24-27, 2004.
2002/2003 Abstracts
Ofotokun, I., Rapp, R.P., Empey, K., Martin, C., Armitstead, J., Pomeroy,
C., Evans, M.E. Results of a four-year effort to control
the use of antimicrobial agents at a university-affiliated hospital. Infectious
Diseases Society of America (IDSA) Annual Meeting, Chicago, October ,
2002.
Campion, J.J., Evans, M.E., McNamara,
P. J. Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus
aureus. American Association of Pharmaceutical Scientists Annual
Meeting and Exposition, Toronto, Canada, November, 2002.
Chung, P., Evans, M.E., Moscow,
J., McNamara, P. J. Development of a molecular beacon-based real-time
PCR assay to detect and quantify the grlA gene of Staphylococcus aureus.
American Association of Pharmaceutical Scientists Annual Meeting and Exposition,
Toronto, Canada, November, 2002.
Martin, C.A., Berry, S.E., and Evans, M.E.
Improvement in the timing of perioperative antimicrobial prophylaxis when
administered upon induction of anesthesia. Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC), September 14-17, 2003,
Chicago.
Campion, J. J, McNamara, P. J.,
and Evans, M.E. Selection of fluoroquinolone-resistant
methicillin resistant Staphylococcus aureus: comparison of garenoxacin,
gatifloxacin, and ciprofloxacin. Interscience Conference on Antimicrobial
Agents and Chemotherapy (ICAAC), September 14-17, 2003, Chicago.
|
